CD155 Antibody Soars to 406 million , witnessing a CAGR of 11.9 during the forecast period 2025-2033

The CD155 antibody market is booming, projected to reach $1 billion by 2033 with a CAGR of 11.9%. Driven by advancements in antibody engineering and rising disease prevalence, key players like Sino Biological and Abcam dominate this rapidly expanding sector. Explore market trends and insights now.


Total Amount: $0
$6960.00
$5220.00
$3480.00

Our Clients

Choose Payment Method

Setting up secure checkout...
Secure Encrypted Transaction
Or

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Key Highlights of Report

Jan, 2026
100
Tables
Base Year: 2025.
Coverage: 18 Countries
Companies: 15+

Connect With us


avatar

Craig Francis

Head Of Sales

Email: [email protected]

+1 2315155523